Cite
HARVARD Citation
Dragoljevic, D. et al. (2023). Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis. Clinical & translational immunology. 12 (4), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Dragoljevic, D. et al. (2023). Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis. Clinical & translational immunology. 12 (4), p. n/a. [Online].